How close are psychedelic therapies to coming to market? What federal and state hurdles still need to be cleared? Karen Luong, co-founder of Husch Blackwell's Psychedelics and Emerging Therapies team, joins CLYDE Managing Director Lisa Josephy to break down the current state of play.